Altamira Therapeutics
CYTO
#10401
Rank
HK$8.8 M
Marketcap
๐Ÿ‡ง๐Ÿ‡ฒ
Country
HK$2.33
Share price
0.00%
Change (1 day)
-84.23%
Change (1 year)

EPS for Altamira Therapeutics (CYTO)

EPS in 2019 (TTM): -HK$2,414

According to Altamira Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2,391. In 2018 the company made an earnings per share (EPS) of -HK$3,368 an increase over its 2017 EPS that were of -HK$18,201.

EPS history for Altamira Therapeutics from 2013 to 2019

Annual EPS

Year EPS Change
2019 (TTM)-HK$2,414-28.32%
2018-HK$3,368-81.5%
2017-HK$18,201-36.52%
2016-HK$28,673-5.17%
2015-HK$30,2357.77%
2014-HK$28,0530.33%
2013-HK$27,960